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Radical cyclization of o-ethenyltrichloroacetanilides in boiling 1,4-dimethylpiperazine was 
examined with a comparison of the mode of radical cyclizations under a Bu3SnH-mediated 
condition.  It was found that an attack of a hydrogen atom on the cyclized radical 
intermediates occurred more rapidly in 1,4-dimethylpiperazine than under the 
Bu3SnH-mediated condition.  This phenomenon was also observed in similar reactions of 
N-ethenyltrichloroacetamide.  
 






A previous study in our laboratory revealed that treatment of N-allylic trichloroacetamides 
1 in boiling 1,4-dimethylpiperazine gave the corresponding 5-membered lactams 2 in good 
yields (Scheme 1).1  Formation of 2 might be a result of radical cyclization that proceeded 
via a single electron transfer reaction from the nitrogen atom of 1,4-dimethylpiperazine to 
the precursor 1.  This reaction will provide an unprecedented method for radical cyclization 
without using a combination of a radical initiator such as azobis(isobutyronitrile) (AIBN) 




















      
     We have now examined the reaction of o-ethenyltrichloroacetanilides in boiling 
1,4-dimethylpiperazine with a comparison of the mode of radical cyclizations under a 
Bu3SnH-mediated condition, and found that an attack of a hydrogen atom on the cyclized 
radical intermediates occurred more rapidly in 1,4-dimethylpiperazine than under the 
Bu3SnH-mediated condition.  This phenomenon was also observed in similar reactions of 
N-ethenyltrichloroacetamide.  The results of our works in this area are presented in this 
paper.  
 
Results and Discussion 
  
o-Ethenyltrichloroacetanilide 3 was prepared by acylation of o-ethenyl-N-methylaniline 
with trichloroacetyl chloride.  When compound 3 was heated in boiling 
1,4-dimethylpiperazine for 20 min, cyclized product 4 was obtained in 76% yield 
(Scheme 2).  On the other hand, treatment of 3 with Bu3SnH in the presence of AIBN 
(using the slow addition technique) in boiling chlorobenzene gave two compounds 5 and 





























Scheme 2.  
 
     Formation of 4 from 3 can be explained as follows (Scheme 3).  A single electron 
 
 transfer reaction from a nitrogen atom of 1,4-dimethylpiperazine (1,4-DMP) to the 
starting compound  3 gives radical anion A together with radical cation B.  Removal of 
the chloride anion of A affords radical C, which then undergoes cyclization in a 
6-exo-trig manner to give cyclized radical D.  An attack of radical D on the hydrogen 
atom of radical cation B or 1,4-dimethylpiperazine (1,4-DMP) itself followed by 










































     Formation of 5 from 3 may proceed via an attack of Bu3SnH on the radical center of D 
and successive reduction of the two chlorine atoms by Bu3SnH.  Formation of 
7-membered unsaturated lactam 6 was presumed to be not a result of a direct 7-endo 
cyclization of the radical formed from 3 but a result of a neophyl rearrangement of 























     When the concentration of the hydrogen atom source is high in the radical reaction 
media, an initially cyclized radical intermediate (such as D) is rapidly reduced by an 
 
 attack of a hydrogen atom, whereas when the concentration of the hydrogen atom source 
is low, the cyclized radical can undergo another reaction such as neophyl rearrangement 
before attack by a hydrogen atom.  Therefore, no formation of the neophyl rearrangement 
product in boiling 1,4-dimethylpiperazine might indicate that the concentration of the 
hydrogen atom source was high, and formation of neophyl rearrangement product 6 from 
3 showed that the concentration of the hydrogen atom source under the Bu3SnH-mediated 
condition was low. 
     Treatment of compound 7 in boiling 1,4-dimethylpiperazine afforded 8 and 9 in 65% 
and 14% yields, respectively, whereas reaction of 7 under the AIBN-Bu3SnH condition 



































Scheme 5.  
 
     It is assumed that compounds 8 and 10 are 6-exo cyclization products and that 
compounds 9 and 11 are neophyl rearrangement products.  The product ratio of 6-exo 
cyclization product 8 and a neophyl rearrangement product 9 in boiling 
1,4-dimethylpiperazine was 4.6:1 and that of 10:11 under the Bu3SnH-mediated 
condition was 1.4:1.  These results also indicated that the concentration of the hydrogen 
atom source was higher in boiling 1,4-dimethylpiperpazine than under the 
Bu3SnH-mediated condition.  
     The cyclization of 12, which was prepared by N-methylation of 
o-(1-methylethenyl)trichloroacetanilide, in boiling 1,4-dimethylpiperazine gave 6-exo 
cyclization products 13 and 14 and the neophyl rearrangement product 15 in 33%, 11% 
and 36% yields, respectively, and the reaction of 12 with AIBN-Bu3SnH gave the 
neophyl rearrangement product 15 and 16 and 7-endo cyclization product 17 in 10%, 
 
 36% and 5% yields, respectively (Scheme 6).  No formation of a 6-exo cyclization 
product under the Bu3SnH-mediated conditions also strongly indicated that the 


















































     It is recognized that 5-endo-trig cyclization of 4-pentenyl radicals is a disfavored 
process due to the stereoelectronic disadvantage in the attack of the radical center on the 
alkenic bond.9  We have found, however, that 5-endo-trig radical cyclizations occurred 
smoothly in some N-vinylic α-haloacetamides.10  We turned our attention to enamide 18, 
which was prepared by trichloroacetylation of imine from 
2,2-bis(phenylthio)acetaldehyde and benzylamine. 
     We could not isolate any cyclized product by heating 18 in boiling 
1,4-dimetylpiperazine but obtained mono-dechlorinated compound 19 in 26% yield 
(Scheme 7).  On the other hand, compound 20 was isolated in 18% yield together with 
several unidentified products by treatment of 18 with AIBN and Bu3SnH in boiling 




























     Formation of 20 could be explained by 5-endo-trig cyclization of radical G followed 

























     When the concentration of the hydrogen atom source is high, a 4-pentenyl radical 
intermediate such as G may be reduced immediately by a hydrogen atom.  Therefore, it is 
assumed that heating 18 in boiling 1,4-dimethylpiparazine, in which the concentration of 
the hydrogen atom source is high, gives the reduction product, and cyclized products are 
obtained under the Bu3SnH-mediated condition, in which the concentration of the 
hydrogen atom source is low. 
     In conclusion, radical cyclizations of a range of 2-ethenyltrichloroacetanilides in 
boiling 1,4-dimethylpiperazine and under Bu3SnH-mediated conditions have revealed 
that the condition using 1,4-dimethylpiperazine works more effectively as a hydrogen 





To a solution of 2-ethenyl-N-methylaniline11 (344 mg, 2.58 mmol) in CH2Cl2 (10 mL) 
were added trichloroacetyl chloride (0.35 mL. 3.10 mmol) and triethylamine (0.54 mL, 
 
 3.87 mmol) at 0 °C and the mixture was stirred at room temperature for 10 min.  The 
reaction mixture was diluted with water and extracted CH2Cl2, and the extract was dried 
(MgSO4) and concentrated.  The residue was chromatographed on silica gel 
(hexane/AcOEt, 20:1) to give 3 (691 mg, 96%) as an oil, whose 1H and 13C NMR spectra 
showed it to be a mixture of rotamers; IR (CHCl3) cm-1: 1680; 1H NMR (270 MHz, 
CDCl3) δ: 3.32 (3H x 3/5, br s), 3.62 (3H x 2/5, br s), 5.41 (1H, d, J=11.0 Hz), 5.80 (1H, 
dd, J=17.5, 1.0 Hz), 6.77 (1H, m), 7.26-7.40 (3H, m), 7.63 (1H, d, J=7.6 Hz); 13C NMR 
(125 MHz, CDCl3) δ: 42.2, 80.4, 117.3, 126.2, 128.3, 129.1, 129.4, 131.0, 131.9, 135.4, 
140.1; HRMS Calcd for C11H10Cl3NO: 276.9828, found: 276.9826. 
 
3-Chloro-1,4-dimethylquinolin-2(1H)-one (4). 
A solution of compound 3 (163 mg, 0.59 mmol) in 1,4-dimethylpiperazine (60 mL) was 
heated at reflux for 20 min.  The reaction mixture was diluted with water and extracted 
with CH2Cl2.  The organic layer was dried (MgSO4) and concentrated, and the residue 
was chromatographed on silica gel (hexane/AcOEt, 10:1) to give 4 (94 mg, 76%) as 
colorless crystals; mp 186-186.5 °C (from hexane). IR (CHCl3) cm-1: 1640.  1H NMR 
(270 MHz, CDCl3) δ:  2.65 (3H, s), 3.80 (3H, s), 7.30 (2H, ddd, J=8.1, 7.1, 1.2 Hz), 7.39 
(1H, dd, J=8.4, 0.8 Hz), 7.59 (1H, ddd, J=8.7, 7.2, 1.5 Hz), 7.77 (1H, dd, J=8.1, 1.5 Hz); 
13C NMR (125 MHz, CDCl3) δ: 16.4, 30.7, 114.5, 120.6, 122.6, 125.4, 126.3, 130.4, 
137.9, 142.4, 158.0.  Anal.  Calcd for C11H10 ClNO: C, 63.62; H, 4.85; N, 6.75.  Found: C, 
63.70; H, 4.84; N, 6.79. 
 
3,4-Dihydro-1,4-dimethylquinolin-2(1H)-one (5) and 
1,5-dihydro-1-methyl-2H-1-benzazepin-2-one (6). 
A solution of AIBN (16 mg, 0.1 mmol) and Bu3SnH (218 mg, 0.75 mmol) in 
chlorobenzene (25 mL) was added dropwise using a syringe pump to a solution of 3 (139 
mg, 0.5 mmol) in chlorobenzene (25 mL) at reflux during 1.5 h.  After consumption of the 
starting material, to the reaction mixture was added a solution of AIBN (16 mg, 0.1 
mmol) and Bu3SnH (218 mg, 0.75 mmol) in chlorobenzene (2 mL) and the mixture was 
heated at reflux for 30 min.  The solvent was removed and the residue was 
chromatographed on silica gel containing KF (10%) (hexane/AcOEt, 4:1).  The first 
eluate gave 512 (28 mg, 32%) as an oil; IR (CHCl3) cm-1: 1655; 1H NMR (500 MHz, 
CDCl3) δ:  1.28 (3H, d, J=7.1 Hz), 2.46 (1H, dd, J=15,9, 7.6 Hz), 2.73 (1H, dd, J=15.8, 
 
 5.5 Hz), 3.02-3.10 (1H, m), 3.37 (3H, s), 6.99-7.07 (2H, m), 7.19-7.30 (2H, m); 13C NMR 
(125 MHz, CDCl3) δ:  19.2, 29.4, 30.3, 39.1, 114.7, 123.0, 126.2, 127.4, 131.0, 139.8, 
169.8; HRMS Calcd for C11H13NO: 175.0997, found: 175.0996.  The second eluate gave 
6 (22 mg, 25%) as an oil; IR (CHCl3) cm-1: 1665; 1H-NMR (500 MHz, CDCl3) δ: 3.29 
(2H, br s), 3.51 (3H, s), 5.91 (1H, d, J=10.7 Hz), 6.60 (1H, dt, J=10.7, 2.9 Hz), 7.10-7.15 
(2H, m), 7.22-7.29 (2H, m);  13C NMR (125 MHz, CDCl3) δ: 32,1, 37.0, 122.1. 125.3, 
125.4, 127.2, 127.7, 136.6, 141.3, 141.8, 167.2; HRMS Calcd for C11H11NO: 173.0841, 
found: 173.0839. 
   
N-Methyl-2’-(1-propenyl)trichloroacetanilide (7).   
According to a procedure similar to that described above for 3, 
N-methyl-2-(1-propenyl)aniline13 (1.79 g, 12.09 mmol) was acetylated with 
trichloroacetyl chloride (1.6 mL. 14.51 mmol) to give 7 (1.78 g, 81%) as colorless 
crystals, whose 1H and 13C NMR spectra showed it to be a mixture of rotamers; mp 
88-89 °C (from hexane); 1H NMR (500 MHz, CDCl3) δ:  1.91 (3H, d, J=5.6 Hz), 3.31 
(3H x 9/14, br s), 3.59 (3H x 5/14, br s), 6.22-6.44 (2H, m), 7.24-7.36 (3H, m), 7.54 (1H, 
d, J=7.6 Hz); 13C NMR (125 MHz, CDCl3) δ: 18.9, 42.1, 126.0, 126.1, 126.7, 127.1, 
128.4, 129.0, 129.5, 135.8, 139.4, 161.0.  Anal.  Calcd for C12H12Cl3NO: C, 49.26; H, 
4.13; N, 4.79.  Found: C, 49.25; H, 4.13; N, 4.80. 
 
3-Chloro-4-ethyl-1-methylquinolin-2(1H)-one (8) and 
3-chloro-1,5-dihydro-1,5-dimethyl-2H-1-benzazepin-2-one (9). 
A solution of compound 7 (146 mg. 0.5 mmol) in 1,4-dimethylpiperazine (2 mL) was 
heated at reflux for 20 min.  A work-up similar to that described above for 4 and the crude 
materials were purified by chromatography on silica gel (hexane/AcOEt, 10:1).  The first 
eluate gave 9 (16 mg, 14%) as an oil; IR (CHCl3) cm-1: 1645; 1H NMR (500 MHz, 
CDCl3) δ: 1.53 (3H, d, J=7.1 Hz), 3.55 (3H, s), 3.57-3.58 (1H, m), 6.43 (1H, d, J=5.9 Hz), 
7.23-7.50 (4H, m); 13C NMR (125 MHz, CDCl3) δ:  15.7, 33.2. 38.0, 122.6, 122.9, 125.9, 
127.0, 128.8, 140.3, 141.2, 144.6, 163.4;  HRMS Calcd for C12H12ClNO: 221.0607, 
found: 221.0610.  The second eluate gave 8 (72 mg, 65%) as colorless crystals; mp 
91.5-92 °C (from hexane); IR (CHCl3) cm-1: 1640. 1H NMR (500 MHz, CDCl3) δ: 1.28 
(3H, t, J=7.6 Hz), 3.10 (2H, q, J=7.6 Hz), 3.79 (3H, s), 7.27-7.32 (1H, m), 7.39 (1H, d, 
J=8.5 ), 7.57-7.60 (1H, m), 7.77 (1H, d, J=8.3 Hz). 13C NMR (125 MHz, CDCl3) δ:  12.5, 
 
 23.3, 30.7, 114.7, 119.4, 122.6, 125.1, 125.4, 130.3, 138.3, 147.8, 158.1.  Anal.  Calcd for 
C12H12ClNO: C, 65.02; H, 5.46; N, 6.32.  Found: C, 64.88; H, 5.46; N, 6.53. 
 
4-Ethyl-3,4-dihydro-1-methylquinolin-2(1H)-one (10) and 
1,5-dihydro-1,5-dimethyl-2H-1-benzazepin-2-one (11). 
Using a procedure similar to that described above for the preparation of 5 and 6, 
compound 7 (146 mg, 0.5 mmol) was treated twice with AIBN (16 mg, 0.1 mmol) and 
Bu3SnH (218 mg, 0.75 mmol).  After a usual work-up, the residue was chromatographed 
on silica gel (hexane/AcOEt, 5:1).  The first eluate gave 1011 (38 mg. 40%) as an oil; IR 
(CHCl3) cm-1: 1660; 1H NMR (500 MHz, CDCl3) δ: 0.93 (3H, t, J=7.6 Hz), 1.52-1.64 (2H, 
m), 2.61 (1H, dd, J=11.6, 6.1 Hz), 2.73-2.77 (2H, m), 3.35 (3H, s), 6.99-7.04 (2H, m), 
7.14-7.16 (1H, m), 7.24-7.29 (1H, m); 13C NMR (125 MHz, CDCl3) δ: 11.4, 26.4, 29.2, 
36.6, 37.6, 114.8, 122.6, 127.3, 127.7, 129.7, 139.7, 169.7.  The second eluate gave 11 (27 
mg, 29%) as an oil; IR (CHCl3) cm-1: 1655; 1H NMR (500 MHz, CDCl3) δ: 1.53 (3H, d, 
J=6.8 Hz), 3.51 (3H, s), 3.62 (1H, br s), 5.82 (1H, d, J=10.5 Hz), 6.28 (1H, br), 7,17-7.28 
(4H, m); 13C NMR (125 MHz, CDCl3) δ: 16.0, 29.7, 37.1, 122.3, 123.4, 125.4, 126.8, 
127.1, 140.6, 141.7, 148.5, 167.3;   HRMS Calcd for C12H13NO: 187.0997, found: 
187.0997.  
      
N-Methyl-2’-(1-methylethenyl)trichloroacetanilide (12).   
According to a procedure similar to that described above for 3, 
2’-(1-methylethenyl)trichloroacetanilide (2.20 g, quant.) was prepared from 
2-(1-methylethenyl)aniline (1.0 mL, 7.34 mmol) and trichloroacetyl chloride (1.0 mL, 
8.81 mmol).  To a suspension of sodium hydride (289 mg. 7.22 mmol) in a combined 
solvent of THF and DMF = 1:1 (2 mL) was added a solution of 
2’-(1-methylethenyl)trichloroacetanilide (1.34 g, 4.81.mmol) in THF (4 mL) at 0 °C and 
the mixture was stirred at the same temperature for 10 min.  Methyl iodide (0.45 mL, 7.22 
mmol) was added to the mixture and the mixture was stirred at room temperature for 30 
min.  The reaction mixture was diluted with water and extracted with AcOEt.  The 
organic layer was washed with brine, dried (MgSO4), and concentrated.  The residue was 
chromatographed on silica gel (hexane/AcOEt, 30:1) to give 12 (1.18 g, 84%) as colorless 
crystals, whose 1H and 13C NMR spectra showed it to be a mixture of rotamers; mp 
35-35.5 °C (from hexane); IR (CHCl3) cm-1: 1685; 1H NMR (270 MHz, CDCl3) δ: 2.08 
 
 (3H, s), 3.31 (3H x 1/5, br s), 3.62 (3H x 4/5, s), 4.98 (1H, br s), 5.21 (1H, br s), 7.19-7.35 
(4H, m); 13C-NMR (125 MHz, CDCl3) δ: 23.4, 41.7, 115.9, 127.3, 127.9, 128.2, 128.4, 
129.7, 140.8, 141.3, 142.1, 160.0.  Anal.  Calcd for C12H12Cl3NO: C, 49.26; H, 4.13; N, 
4.79.  Found: C, 49.15; H, 4.11; N, 4.72. 
 
3,3-Dichloro-3,4-dihydro-1,4,4-trimethylquinolin-2(1H)-one (13), 
3-chloro-3,4-dihydro-1,4,4-trimethylquinolin-2(1H)-one (14) and 
3-chloro-1,5-dihydro-1,4-dimethyl-2H-1-benzazepin-2-one (15).   
A solution of compound 12 (146 mg. 0.5 mmol) in 1,4-dimethylpiperazine (2 mL) was 
heated at reflux for 20 min.  After a work-up similar to that described above for 4, the 
residue was chromatographed on silica gel (hexane/AcOEt, 10:1).  The first eluate gave 
13 (43 mg, 33%) as colorless crystals; mp 96-97 °C (from hexane); IR (CHCl3) cm-1: 
1690; 1H NMR (500 MHz, CDCl3) δ: 1.30 (3H, s), 1.80 (3H, s), 3.52 (3H, s), 7.07 (1H, d, 
J=8.3 Hz), 7.14-7.17 (1H, m), 7.32-7.37 (2H, m); 13C NMR (125 MHz, CDCl3) δ: 20.8, 
25.1, 31.5, 46.8, 92.6, 115.2, 124.3, 125.1, 128.2, 131.7, 137.3, 161.9.  Anal.  Calcd for 
C12H13Cl2NO: C, 55.83; H, 5.08; N, 5.43.  Found: C, 55.66; H, 5.07; N, 5.36.  The second 
eluate gave 14 (12 mg, 11%) as colorless crystals; mp 91-92 °C (from hexane); IR 
(CHCl3) cm-1: 1680; 1H NMR (500 MHz, CDCl3) δ: 1.31 (3H, s), 1.48 (3H, s), 3.44 (3H, 
s), 4.25 (1H, s), 7.06-7.34 (4H, m);  13C NMR (125 MHz, CDCl3) δ: 23.1, 26.1, 30.0, 38.5, 
64.7, 115.1, 123.9, 125.2, 127.9, 131.2, 138.0, 165.3.  Anal.  Calcd for C12H14ClNO: C, 
64.43; H, 6.31; N, 6.26.  Found: C, 64.08; H, 6.30; N, 6.30.  The third eluate gave 15 (40 
mg, 36%) as an oil; IR (CHCl3) cm-1: 1645; 1H NMR (500 MHz, CDCl3) δ: 2.11 (3H, s), 
2.99 (1H, d, J=13.4 Hz), 3.55 (3H, s), 3.64 (1H, d, J=13.4 Hz), 7.13-7.31 (4H, m); 13C 
NMR (125 MHz, CDCl3) δ: 21.8, 37.6, 37.9, 121.0, 122.2, 125.7, 127.0, 127.6, 135.6, 
141.2, 146.5, 164.1;  HRMS Calcd for C12H12ClNO: 221.0607, found: 221.0606. 
 
1,5-Dihydro-1,4-dimethyl-2H-1-benzazepin-2-one (16) and 
1,3,4,5-tetrahydro-1,5-dimethyl-2H-1-benzazepin-2-one (17). 
 Using a procedure similar to that described above for the preparation of 5 and 6, 
compound 12 (146 mg, 0.5 mmol) was treated twice with AIBN (16 mg, 0.1 mmol) and 
Bu3SnH (218 mg, 0.75 mmol).  After a usual work-up, the residue was chromatographed 
on silica gel (hexane/AcOEt, 3:1).  The first eluate gave 1714 (5 mg, 5%) as an oil; IR 
(CHCl3) cm-1: 1650; 1H NMR (500 MHz, CDCl3) δ: 1.35 (3H, d, J=6.8 Hz), 1.56-1.63 
 
 (1H, m), 2.20-2.30 (2H, m), 2.37-2.45 (1H, m), 2.99-3.07 (1H, m), 3.34 (3H, s), 7.16-7.31 
(4H, m); 13C NMR (125 MHz, CDCl3) δ: 17.8, 32.6, 33.5, 35.1, 37.5, 122.3, 125.2, 126.2, 
127.0, 138.6, 143.5, 173.4.  The second eluate gave 15 (11 mg, 10%) as an oil.  The third 
eluate gave 1611 (34 mg, 36%) as colorless crystals; mp 95.5-96.5 °C (from hexane), lit.11 
96-97 °C (from hexane); IR (CHCl3) cm-1: 1660; 1H NMR (500 MHz, CDCl3) δ: 1.97 (3H, 
s), 3.24 (2H, br), 3.49 (3H, s), 5.69 (1H, s), 7.09-7.28 (4H, m); 13C NMR (125 MHz, 
CDCl3) δ: 24.3, 36.6, 38.0, 120.0, 121.6, 125.1, 127.2, 127.3, 135.5, 141.8, 152.8, 
167.4.   . 
 
N-Benzyl-N-[2,2-bis(phenylthio)ethenyl]trichloroacetamide (18). 
To a solution of 2,2-bis(phenylthio)acetaldehyde15 (1.44 g, 5.33 mmol) in Et2O (30 mL) 
were added benzylamine (0.6 mL, 5.33 mmol) and MgSO4 (10 g), and the mixture was 
stirred at room temperature for 3 h.  The reaction mixture was filtered and the filtrate was 
concentrated.  To a solution of this residue in toluene (50 mL) were added trichloroacetyl 
chloride (0.93 mL, 8.3 mmol) and N,N-diethylaniline (1.76 ml, 11.06 mmol) and the 
mixture was heated under reflux for 2 h.  The reaction mixture was diluted with water and 
extracted with AcOEt.  The extract was washed with brine, dried (MgSO4), and 
concentrated.  The residue was chromatographed on silica gel (hexane/AcOEt, 60:1→
30:1) to give 18 (2.18 g, 80%) as an oil; IR (CHCl3) cm-1: 1685; 1H NMR (270 MHz, 
CDCl3) δ: 5.12 (2H, s), 6.87 (1H, s), 7.05-7.39 (15H, m); 13C NMR (125 MHz, CDCl3) δ: 
54.0, 92.9, 127.9, 128.0, 128.2, 128.4, 128.71, 128.73, 128.9. 129.8, 130.5, 131.8, 132.5, 




A solution of compound 18 (49.5 mg, 0.1 mmol) in 1,4-dimethylpiperazine (5 mL) was 
heated at reflux for 30 min.  After a work-up similar to that described above for 4, the 
residue was chromatographed on silica gel (hexane/AcOEt, 30:1→10:1) to give 19 (12 mg, 
26%) as an oil; IR (CHCl3) cm-1: 1690; 1H NMR (500 MHz, CDCl3) δ: 4.81 (2H, s), 6.24 
(1H, s), 6.36 (1H, br s), 7.08-7.44 (15H, m); 13C-NMR (125 MHz, CDCl3) δ: 51.1, 65.1, 
126.7, 127.9, 128.4, 128.7, 128.9, 129.1, 129.7, 131.6, 132.3, 133.8, 135.5, 139.6, 163.5; 




Using a procedure similar to that described above for the preparation of 5 and 6, 
compound 18 (1.34 g, 2.71 mmol) was treated twice with AIBN (89 mg, 0.54 mmol) and 
Bu3SnH (867 mg, 2.98 mmol).  After a usual work-up, the residue was chromatographed 
on silica gel (hexane/AcOEt, 10:1→5:1→3:1) to give 20 (154 mg, 18%) as colorless 
crystals; mp 38-39 °C; IR (CHCl3) cm-1: 1695; 1H NMR (500 MHz, CDCl3) δ: 3.53 (2H, 
s), 4.55 (2H, s), 7.14 (2H, d, J=6.7 Hz), 7.23-7.50 (8H, m); 13C NMR (125 MHz, CDCl3) 
δ: 46.9, 51.6, 121.1, 127.3, 127.68, 127.75, 128.7, 129.8, 130.0, 134.7, 136.4, 146.7, 
165.2; HRMS Calcd for C17H14ClNOS: 315.0485, found: 315.0491.   
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